MedTrace Logo

Evaluation of the Performance and Safety of Two Intradermal Delivery Devices.

NCT01943110 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2016-03-02

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate whether two intradermal (ID) vaccine delivery devices can safely and precisely inject liquid into the intradermal layer of the skin in three different injection locations

Conditions

  • Injections, Intradermal

Interventions

DEVICE

ID adapter (autodisable)

Intradermal delivery device which fits on the end of a syringe to limit the depth and angle of needle penetration into the skin. Contains an autodisable feature to prevent reuse.

DEVICE

ID adapter (side load)

Intradermal delivery device which fits on the end of a syringe to limit the depth and angle of needle penetration into the skin.

Sponsors & Collaborators

  • SID Technologies

    collaborator UNKNOWN

  • PATH

    lead OTHER

Principal Investigators

  • Leslie Klaff, MD, PhD · Rainier Clinical Research Center

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2013-07-31
Completion
2013-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01943110 on ClinicalTrials.gov